Isomorphic Labs
Isomorphic Labs is an Alphabet-owned AI drug discovery company spun out of DeepMind in 2021.
Isomorphic Labs is an Alphabet-owned drug discovery company founded in 2021 as a spinout of DeepMind, now Google DeepMind. DeepMind co-founder Demis Hassabis also serves as its chief executive, and the company is based in London.
It uses AI to predict protein structures and interactions between molecules in search of drug candidates, and it developed the protein structure prediction model AlphaFold 3 together with Google DeepMind.
This entry is based on AIPOST articles and widely known facts. If something is wrong, please send us a correction request.